Potential estrogenic effect(s) of parabens at the prepubertal stage of a postnatal female rat model

Reproductive Toxicology

Volumn 29, Issue 3, 2010, Pages 306-316

  Vo, Thuy T B ^a   Yoo, Yeong Min ^a   Choi, Kyung Chul ^a   Jeung, Eui Bae ^a  

^a Chungbuk National University   (South Korea)

Author keywords

Endocrine disruptors; Estrogenicity; Female rats; Parabens

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; BUTYL PARABEN; ESTRADIOL; ESTROGEN RECEPTOR; ETHINYLESTRADIOL; ETHYL PARABEN; ISOBUTYL PARABEN; ISOPROPYL PARABEN; METHYL PARABEN; PROPYL PARABEN; THYROID HORMONE; THYROXINE; UNCLASSIFIED DRUG;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BODY WEIGHT; CONTROLLED STUDY; CORPUS LUTEUM; DEVELOPMENTAL DISORDER; ESTRADIOL BLOOD LEVEL; ESTRUS CYCLE; FEMALE; HISTOPATHOLOGY; MUSCLE HYPERTROPHY; MYOMETRIUM; NONHUMAN; ORGAN WEIGHT; OVARY; POSTNATAL DEVELOPMENT; PREPUBERTY; RAT; RECEPTOR BINDING; REPRODUCTIVE TOXICITY; THYROID GLAND; THYROID WEIGHT; THYROXINE BLOOD LEVEL; WEIGHT CHANGE;

ADRENAL GLANDS; ANIMALS; ENDOCRINE SYSTEM DISEASES; ESTRADIOL; ESTROUS CYCLE; ETHINYL ESTRADIOL; FEMALE; LIVER; ORGAN SIZE; PARABENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; REPRODUCTION; RISK FACTORS; THYROID GLAND; THYROID HORMONES; THYROXINE; UTERUS; VAGINA;

RATTUS; ZEA MAYS;

EID: 77951622226     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2010.01.013     Document Type: Article

References (71)

1. Hossaini A., Larsen J.J., Larsen J.C. Lack of oestrogenic effects of food preservatives (parabens) in uterotrophic assays. Food Chem Toxicol 2000, 38:319-323.
2. Shen H.Y., Jiang H.L., Mao H.L., Pan G., Zhou L., Cao Y.F. Simultaneous determination of seven phthalates and four parabens in cosmetic products using HPLC-DAD and GC-MS methods. J Sep Sci 2007, 30:48-54.
3. Byford J.R., Shaw L.E., Drew M.G., Pope G.S., Sauer M.J., Darbre P.D. Oestrogenic activity of parabens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol 2002, 80:49-60.
4. Okubo T., Yokoyama Y., Kano K., Kano I. ER-dependent estrogenic activity of parabens assessed by proliferation of human breast cancer MCF-7 cells and expression of ERalpha and PR. Food Chem Toxicol 2001, 39:1225-1232.
5. Pugazhendhi D., Pope G.S., Darbre P.D. Oestrogenic activity of p-hydroxybenzoic acid (common metabolite of paraben esters) and methylparaben in human breast cancer cell lines. J Appl Toxicol 2005, 25:301-309.
6. Vanparys C., Maras M., Lenjou M., Robbens J., Van Bockstaele D., Blust R., et al. Flow cytometric cell cycle analysis allows for rapid screening of estrogenicity in MCF-7 breast cancer cells. Toxicol In Vitro 2006, 20:1238-1248.
7. Ge J.H., Chang B. Estrogenic activities of parabens. Wei Sheng Yan Jiu 2006, 35:650-652.
8. Lemini C., Jaimez R., Avila M.E., Franco Y., Larrea F., Lemus A.E. In vivo and in vitro estrogen bioactivities of alkyl parabens. Toxicol Ind Health 2003, 19:69-79.
9. Oishi S. Lack of spermatotoxic effects of methyl and ethyl esters of p-hydroxybenzoic acid in rats. Food Chem Toxicol 2004, 42:1845-1849.
10. Oishi S. Effects of propyl paraben on the male reproductive system. Food Chem Toxicol 2002, 40:1807-1813.
11. Oishi S. Effects of butyl paraben on the male reproductive system in mice. Arch Toxicol 2002, 76:423-429.
12. Harvey P.W. Parabens, oestrogenicity, underarm cosmetics and breast cancer: a perspective on a hypothesis. J Appl Toxicol 2003, 23:285-288.
13. Darbre P.D., Byford J.R., Shaw L.E., Hall S., Coldham N.G., Pope G.S., et al. Oestrogenic activity of benzylparaben. J Appl Toxicol 2003, 23:43-51.
14. Kang K.S., Che J.H., Ryu D.Y., Kim T.W., Li G.X., Lee Y.S. Decreased sperm number and motile activity on the F1 offspring maternally exposed to butyl p-hydroxybenzoic acid (butyl paraben). J Vet Med Sci 2002, 64:227-235.
15. Inui M., Adachi T., Takenaka S., Inui H., Nakazawa M., Ueda M., et al. Effect of UV screens and preservatives on vitellogenin and choriogenin production in male medaka (Oryzias latipes). Toxicology 2003, 194:43-50.
16. Routledge E.J., Parker J., Odum J., Ashby J., Sumpter J.P. Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic. Toxicol Appl Pharmacol 1998, 153:12-19.
17. Darbre P.D., Harvey P.W. Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks. J Appl Toxicol 2008, 28:561-578.
18. Terasaki M., Kamata R., Shiraishi F., Makino M. Evaluation of estrogenic activity of parabens and their chlorinated derivatives by using the yeast two-hybrid assay and the enzyme-linked immunosorbent assay. Environ Toxicol Chem 2008, 1.
19. Gomez E., Pillon A., Fenet H., Rosain D., Duchesne M.J., Nicolas J.C., et al. Estrogenic activity of cosmetic components in reporter cell lines: parabens, UV screens, and musks. J Toxicol Environ Health A 2005, 68:239-251.
20. Satoh K., Nagai F., Aoki N., Nishijima M. [Competitive binding of some alkyl p-hydroxybenzoates to human estrogen receptor alpha and beta]. Yakugaku Zasshi 2000, 120:1429-1433.
21. Russo I.H., Russo J. Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect 1996, 104:938-967.
22. Kang K.S., Kim H.S., Ryu D.Y., Che J.H., Lee Y.S. Immature uterotrophic assay is more sensitive than ovariectomized uterotrophic assay for the detection of estrogenicity of p-nonylphenol in Sprague-Dawley rats. Toxicol Lett 2000, 118:109-115.
23. Newbold R.R., Jefferson W.N., Padilla-Banks E. The mouse uterotrophic assay: other end points. Environ Health Perspect 2001, 109:A569-A570.
24. Kanno J., Onyon L., Haseman J., Fenner-Crisp P., Ashby J., Owens W. The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: phase 1. Environ Health Perspect 2001, 109:785-794.
25. Padilla-Banks E., Jefferson W.N., Newbold R.R. The immature mouse is a suitable model for detection of estrogenicity in the uterotropic bioassay. Environ Health Perspect 2001, 109:821-826.
26. Pugazhendhi D., Sadler A.J., Darbre P.D. Comparison of the global gene expression profiles produced by methylparaben, n-butylparaben and 17beta-oestradiol in MCF7 human breast cancer cells. J Appl Toxicol 2007, 27:67-77.
27. Terasaka S., Inoue A., Tanji M., Kiyama R. Expression profiling of estrogen-responsive genes in breast cancer cells treated with alkylphenols, chlorinated phenols, parabens, or bis- and benzoylphenols for evaluation of estrogenic activity. Toxicol Lett 2006, 163:130-141.
28. Naciff J.M., Overmann G.J., Torontali S.M., Carr G.J., Tiesman J.P., Richardson B.D., et al. Gene expression profile induced by 17 alpha-ethynyl estradiol in the prepubertal female reproductive system of the rat. Toxicol Sci 2003, 72:314-330.
29. Naciff J.M., Jump M.L., Torontali S.M., Carr G.J., Tiesman J.P., Overmann G.J., et al. Gene expression profile induced by 17alpha-ethynyl estradiol, bisphenol A, and genistein in the developing female reproductive system of the rat. Toxicol Sci 2002, 68:184-199.
30. Darbre P.D., Aljarrah A., Miller W.R., Coldham N.G., Sauer M.J., Pope G.S. Concentrations of parabens in human breast tumours. J Appl Toxicol 2004, 24:5-13.
31. Donovan M., Tiwary C.M., Axelrod D., Sasco A.J., Jones L., Hajek R., et al. Personal care products that contain estrogens or xenoestrogens may increase breast cancer risk. Med Hypotheses 2007, 68:756-766.
32. Soni M.G., Carabin I.G., Burdock G.A. Safety assessment of esters of p-hydroxybenzoic acid (parabens). Food Chem Toxicol 2005, 43:985-1015.
33. Ishiwatari S., Suzuki T., Hitomi T., Yoshino T., Matsukuma S., Tsuji T. Effects of methyl paraben on skin keratinocytes. J Appl Toxicol 2007, 27:1-9.
34. Lee G.S., Jeung E.B. Uterine TRPV6 expression during the estrous cycle and pregnancy in a mouse model. Am J Physiol Endocrinol Metab 2007, 293:E132-E138.
35. 2+ ATPase 1b during rat estrous cycle. Am J Physiol Endocrinol Metab 2006, 291:E234-E241.
36. Nguyen T.H., Lee G.S., Ji Y.K., Choi K.C., Lee C.K., Jeung E.B. A calcium binding protein, calbindin-D9k, is mainly regulated by estrogen in the pituitary gland of rats during estrous cycle. Brain Res Mol Brain Res 2005, 141:166-173.
37. Kato H., Ota T., Furuhashi T., Ohta Y., Iguchi T. Changes in reproductive organs of female rats treated with bisphenol A during the neonatal period. Reprod Toxicol 2003, 17:283-288.
38. Boberg J., Metzdorff S., Wortziger R., Axelstad M., Brokken L., Vinggaard A.M., et al. Impact of diisobutyl phthalate and other PPAR agonists on steroidogenesis and plasma insulin and leptin levels in fetal rats. Toxicology 2008, 250:75-81.
39. Taxvig C., Vinggaard A.M., Hass U., Axelstad M., Boberg J., Hansen P.R., et al. Do parabens have the ability to interfere with steroidogenesis?. Toxicol Sci 2008, 106:206-213.
40. Janjua N.R., Mortensen G.K., Andersson A.M., Kongshoj B., Skakkebaek N.E., Wulf H.C. Systemic uptake of diethyl phthalate, dibutyl phthalate, and butyl paraben following whole-body topical application and reproductive and thyroid hormone levels in humans. Environ Sci Technol 2007, 41:5564-5570.
41. Andrews W.W., Mizejewski G.J., Ojeda S.R. Development of estradiol-positive feedback on luteinizing hormone release in the female rat: a quantitative study. Endocrinology 1981, 109:1404-1413.
42. Kawagoe S., Hiroi M. Maturation of negative and positive estrogen feedback in the prepubertal female rat. Endocrinol Jpn 1983, 30:435-441.
43. Rage F., Lee B.J., Ma Y.J., Ojeda S.R. Estradiol enhances prostaglandin E2 receptor gene expression in luteinizing hormone-releasing hormone (LHRH) neurons and facilitates the LHRH response to PGE2 by activating a glia-to-neuron signaling pathway. J Neurosci 1997, 17:9145-9156.
44. Odum J., Lefevre P.A., Tittensor S., Paton D., Routledge E.J., Beresford N.A., et al. The rodent uterotrophic assay: critical protocol features, studies with nonyl phenols, and comparison with a yeast estrogenicity assay. Regul Toxicol Pharmacol 1997, 25:176-188.
45. Singh M.M., Kamboj V.P. Estrogenic and antiestrogenic activities of two new nonsteroidal antifertility agents. Endokrinologie 1980, 76:36-44.
46. Warren M.P., Voussoughian F., Geer E.B., Hyle E.P., Adberg C.L., Ramos R.H. Functional hypothalamic amenorrhea: hypoleptinemia and disordered eating. J Clin Endocrinol Metab 1999, 84:873-877.
47. Rubin B.S., Murray M.K., Damassa D.A., King J.C., Soto A.M. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ Health Perspect 2001, 109:675-680.
48. Goldman J.M., Laws S.C., Balchak S.K., Cooper R.L., Kavlock R.J. Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid activity in the female rat. A focus on the EDSTAC recommendations. Crit Rev Toxicol 2000, 30:135-196.
49. Kwon S., Stedman D.B., Elswick B.A., Cattley R.C., Welsch F. Pubertal development and reproductive functions of Crl:CD BR Sprague-Dawley rats exposed to bisphenol A during prenatal and postnatal development. Toxicol Sci 2000, 55:399-406.
50. Nass T.E., Matt D.W., Judd H.L., Lu J.K. Prepubertal treatment with estrogen or testosterone precipitates the loss of regular estrous cyclicity and normal gonadotropin secretion in adult female rats. Biol Reprod 1984, 31:723-731.
51. Della Seta D., Farabollini F., Dessi-Fulgheri F., Fusani L. Environmental-like exposure to low levels of estrogen affects sexual behavior and physiology of female rats. Endocrinology 2008, 149:5592-5598.
52. Biegel L.B., Cook J.C., Hurtt M.E., O'Connor J.C. Effects of 17 beta-estradiol on serum hormone concentrations and estrous cycle in female Crl:CD BR rats: effects on parental and first generation rats. Toxicol Sci 1998, 44:143-154.
53. Ye X., Bishop A.M., Reidy J.A., Needham L.L., Calafat A.M. Parabens as urinary biomarkers of exposure in humans. Environ Health Perspect 2006, 114:1843-1846.
54. Lee H.B., Peart T.E., Svoboda M.L. Determination of endocrine-disrupting phenols, acidic pharmaceuticals, and personal-care products in sewage by solid-phase extraction and gas chromatography-mass spectrometry. J Chromatogr A 2005, 1094:122-129.
55. Canosa P., Rodriguez I., Rubi E., Bollain M.H., Cela R. Optimisation of a solid-phase microextraction method for the determination of parabens in water samples at the low ng per litre level. J Chromatogr A 2006, 1124:3-10.
56. El Hussein S., Muret P., Berard M., Makki S., Humbert P. Assessment of principal parabens used in cosmetics after their passage through human epidermis-dermis layers (ex-vivo study). Exp Dermatol 2007, 16:830-836.
57. Stoker T.E., Parks L.G., Gray L.E., Cooper R.L. Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid function in the male rat. A focus on the EDSTAC recommendations. Endocrine Disrupter Screening and Testing Advisory Committee. Crit Rev Toxicol 2000, 30:197-252.
58. Malik R., Hodgson H. The relationship between the thyroid gland and the liver. QJM 2002, 95:559-569.
59. Thobe N., Pilger P., Jones M.P. Primary hypothyroidism masquerading as hepatic encephalopathy: case report and review of the literature. Postgrad Med J 2000, 76:424-426.
60. Daston G.P. Developmental toxicity evaluation of butylparaben in Sprague-Dawley rats. Birth Defects Res B Dev Reprod Toxicol 2004, 71:296-302.
61. Hoberman A.M., Schreur D.K., Leazer T., Daston G.P., Carthew P., Re T., et al. Lack of effect of butylparaben and methylparaben on the reproductive system in male rats. Birth Defects Res B Dev Reprod Toxicol 2008, 83:123-133.
62. Nakamura T., Katsu Y., Watanabe H., Iguchi T. Estrogen receptor subtypes selectively mediate female mouse reproductive abnormalities induced by neonatal exposure to estrogenic chemicals. Toxicology 2008, 253:117-124.
63. Reznikov A.G., Sinitsyn P.V., Tarasenko L.V., Polyakova L.I. Neuroendocrine mechanisms of development of experimental hyperandrogen-induced anovulation. Neurosci Behav Physiol 2003, 33:773-776.
64. Nishihara E., Nagayama Y., Inoue S., Hiroi H., Muramatsu M., Yamashita S., et al. Ontogenetic changes in the expression of estrogen receptor alpha and beta in rat pituitary gland detected by immunohistochemistry. Endocrinology 2000, 141:615-620.
65. Noda H., Onishi H., Saitoh K., Nakajima H. Growth hormone therapy may increase fracture risk in a pubertal patient with osteogenesis imperfecta. J Pediatr Endocrinol Metab 2002, 15:217-218.
66. Ceccarelli I., Fiorenzani P., Della Seta D., Massafra C., Cinci G., Bocci A., et al. Perinatal exposure to xenoestrogens affects pain in adult female rats. Neurotoxicol Teratol 2009, 31:203-209.
67. Zoeller R.T. Environmental chemicals impacting the thyroid: targets and consequences. Thyroid 2007, 17:811-817.
68. Zoeller R.T. Environmental chemicals as thyroid hormone analogues: new studies indicate that thyroid hormone receptors are targets of industrial chemicals?. Mol Cell Endocrinol 2005, 242:10-15.
69. Ain K.B., Mori Y., Refetoff S. Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration. J Clin Endocrinol Metab 1987, 65:689-696.
70. Emerson C.H., Cohen J.H., Young R.A., Alex S., Fang S.L. Gender-related differences of serum thyroxine-binding proteins in the rat. Acta Endocrinol (Copenh) 1990, 123:72-78.
71. Moriyama K., Tagami T., Akamizu T., Usui T., Saijo M., Kanamoto N., et al. Thyroid hormone action is disrupted by bisphenol A as an antagonist. J Clin Endocrinol Metab 2002, 87:5185-5190.